Janus Henderson Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Janus Henderson Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-21,845	Closed	-$202K	–	848
2015 Q4	$202K	Hold	21,845	–	–	﹤0.01%	803
2015 Q3	$279K	Hold	21,845	–	–	﹤0.01%	797
2015 Q2	$242K	Hold	21,845	–	–	﹤0.01%	833
2015 Q1	$250K	Sell	21,845 -29,000	-57%	-$308K	﹤0.01%	824
2014 Q4	$513K	Hold	50,845	–	–	﹤0.01%	776
2014 Q3	$534K	Hold	50,845	–	–	0.01%	698
2014 Q2	$439K	Hold	50,845	–	–	﹤0.01%	701
2014 Q1	$447K	Hold	50,845	–	–	﹤0.01%	708
2013 Q4	$417K	Sell	50,845 -38,435	-43%	-$304K	﹤0.01%	695
2013 Q3	$675K	Hold	89,280	–	–	0.01%	632
2013 Q2	$679K	Buy	+89,280	New	+$652K	0.01%	612

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Janus Henderson Group's RDY Position: Q1 2016 in Review

Janus Henderson Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2016, closing a stake of 21,845 shares — an estimated $202K sold.

Janus Henderson Group first reported a position in RDY in Q2 2013 and held it in 11 quarters. The position peaked at $679K in Q2 2013. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2016.

Janus Henderson Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2016 after selling out during the quarter.
Janus Henderson Group sold 21,845 Dr. Reddy's Laboratories shares in Q1 2016, an estimated $202K.
Janus Henderson Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 11 quarters.
Janus Henderson Group's Dr. Reddy's Laboratories position peaked at $679K in Q2 2013.
160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2016.

Based on Janus Henderson Group's 13F filing for Q1 2016, filed 12 May 2016.